Harrington D K, Walker A S, Kaukuntla H, Bracewell R M, Clutton-Brock T H, Faroqui M, Pagano D, Bonser R S
Department of Cardiothoracic Surgery, Queen Elizabeth Hospital, University Hospital Birmingham NHS Trust, Edgbaston, Birmingham, UK.
Circulation. 2004 Sep 14;110(11 Suppl 1):II231-6. doi: 10.1161/01.CIR.0000138945.78346.9c.
Aortic arch surgery has a high incidence of brain injury. This may in part be caused by a cerebral metabolic deficit observed after hypothermic circulatory arrest (HCA). We hypothesized that selective antegrade cerebral perfusion (SACP) would attenuate this phenomenon.
In a prospective randomized trial, 42 adult patients were allocated to either HCA (22) or SACP. HCA occurred at a nasopharyngeal temperature of 15 degrees C and SACP at a corporeal temperature of 25 degrees C with cerebral perfusion at 15 degrees C. Paired arterial and jugular venous samples were taken before and after arrest. Continuous transcranial Doppler monitoring of middle cerebral artery velocity (MCAV) was performed. Neuropsychometric testing was performed preoperatively and at 6 and 12 weeks postoperatively. There were 3 hospital deaths (7.1%), 2 strokes (4.8%), and 6 episodes of transient neurological deficit (14.3%). From before to after arrest, jugular bulb pO2 changed by -21.67 mm Hg (26.4) in the HCA group versus +2.27 mm Hg (18.8) in the SACP group (P=0.007). Oxygen extraction changed by +1.7 mL/dL (1.3) in the HCA group versus -1 mL/dL (2.4) in the SACP group (P<0.001). MCAV increased by 6.25 cm/s (9.1) in the HCA group and 19.2 cm/s (10.1) in the SACP group (P=0.001). Incidence of neuropsychometric deficit at 6 weeks was 6/12 (50%) in HCA patients and 8/10 (80%) in SACP patients (P=0.2), and at 12 weeks was 6/16 (38%) in HCA patients and 4/11 (36%) in SACP patients (P=1).
SACP attenuates the metabolic changes seen after HCA. Further studies are required to assess optimal perfusion conditions and clinical outcome.
主动脉弓手术脑损伤发生率较高。这可能部分是由低温循环停搏(HCA)后观察到的脑代谢缺陷所致。我们推测选择性顺行性脑灌注(SACP)可减轻这一现象。
在一项前瞻性随机试验中,42例成年患者被分为HCA组(22例)或SACP组。HCA在鼻咽温度15℃时进行,SACP在体温25℃时进行,脑灌注在15℃。在停搏前后采集配对的动脉和颈静脉样本。对大脑中动脉速度(MCAV)进行连续经颅多普勒监测。在术前以及术后6周和12周进行神经心理测试。有3例医院死亡(7.1%),2例中风(4.8%),6例短暂性神经功能缺损发作(14.3%)。从停搏前到停搏后,HCA组颈静脉球pO₂变化为-21.67 mmHg(26.4),而SACP组为+2.27 mmHg(18.8)(P = 0.007)。HCA组氧摄取变化为+1.7 mL/dL(1.3),SACP组为-1 mL/dL(2.4)(P < 0.001)。HCA组MCAV增加6.25 cm/s(9.1),SACP组增加19.2 cm/s(10.1)(P = 0.001)。HCA患者6周时神经心理缺陷发生率为6/12(50%),SACP患者为8/10(80%)(P = 0.2),12周时HCA患者为6/16(38%),SACP患者为4/11(36%)(P = 1)。
SACP可减轻HCA后出现的代谢变化。需要进一步研究以评估最佳灌注条件和临床结局。